Workflow
Cigna(CI)
icon
Search documents
Cigna Stock Gains 26% in a Year: What Lies Ahead for Investors?
ZACKS· 2024-09-10 18:02
Shares of The Cigna Group (CI) have gained 25.6% in the past year compared with the industry's 18.2% growth. The Medical sector and the S&P 500 composite index have rallied 9.3% and 21.2%, respectively, in the same time frame. CI has been well-poised for growth on the back of a sound membership base, solid Evernorth unit, acquisitions and expanding cash reserves. Currently priced at $357.40, the stock is just 3.6% below its 52-week high of $370.64. This proximity underscores investor confidence and market o ...
The Cigna Group's "Community Vitality Project" Donates $75,000 to Nonprofits through Program Encouraging Fitness and Community Engagement
Prnewswire· 2024-09-09 11:00
The project culminated with a reception for Boys & Girls Clubs youth, along with Cigna leaders, to watch the Hartford Yard Goats baseball team play a home game at Dunkin' Park. Families were also able to spend time with surprise guests: UConn men's basketball coach Dan Hurley, and UConn basketball players Alex Karaban, KK Arnold and Sarah Strong. "We are excited to capstone The Cigna Group's Community Vitality Project with a bike ride from our headquarters in Bloomfield to Dunkin Park, home of the Yard Goat ...
The Cigna Group (CI) Morgan Stanley 22nd Annual Global Healthcare Conference (Transcript)
2024-09-05 18:39
The Cigna Group (NYSE:CI) Morgan Stanley 22nd Annual Global Healthcare Conference September 5, 2024 10:45 AM ET Company Participants David Cordani - Chairman and CEO Conference Call Participants Erin Wright - Morgan Stanely Erin Wright Good morning, everyone. Welcome to the Morgan Stanley Healthcare Conference. I'm Erin Wright, a healthcare services analyst at Morgan Stanley. We're very happy to have with us a very timely conversation with Cigna today. We have our Chairman and CEO, David Cordani, with us t ...
Evernorth announces another step forward in lowering drug prices by making a Stelara biosimilar available at $0 out of pocket for patients early next year
Prnewswire· 2024-09-05 10:00
Estimated to save individual Accredo patients around $4,000 per year Biosimilar price will be more than 80% lower than Stelara list price Accredo patients benefit from the specialty pharmacy's best-in-class clinical support BLOOMFIELD, Conn., Sept. 5, 2024 /PRNewswire/ -- Evernorth Health Services announced that it plans to have a Stelara biosimilar available for $0 out of pocket for eligible patients of its specialty pharmacy, Accredo, beginning in early 2025. The interchangeable biosimilar will be produce ...
The Cigna Group Announces Appearance at the Morgan Stanley 22nd Annual Global Healthcare Conference
Prnewswire· 2024-08-15 13:00
BLOOMFIELD, Conn., Aug. 15, 2024 /PRNewswire/ -- Global health company The Cigna Group (NYSE:CI) announced today that David Cordani, Chairman and Chief Executive Officer, will present at the Morgan Stanley 22nd Annual Global Healthcare Conference on September 5, 2024, in New York, NY. The Cigna Group's presentation is expected to begin at approximately 10:45 a.m. ET. A live webcast of the presentation will be available at https://investors.thecignagroup.com/events-and-presentations/default.aspx in the Inves ...
The Cigna Group Foundation Launches Grant Program To Improve Veteran Mental Health
Prnewswire· 2024-08-12 11:00
Initiative commits $9M over three years, with a first-year focus on housing stability Request for application now open for nonprofits prioritizing veteran mental health with programs and services directly connected to housing and homelessness challenges BLOOMFIELD, Conn., Aug. 12, 2024 /PRNewswire/ -- The Cigna Group Foundation, the philanthropic arm of The Cigna Group (NYSE: CI), announced today a new grant program that will commit $9 million over three years to help improve the mental health and well-bein ...
The 3 Best Bargain Stocks to Buy in August 2024
Investor Place· 2024-08-07 21:31
Since July 16, volatility in the markets has increased. Stocks have entered correction territory, with the Nasdaq 100 down 13% from its peak. In light of the recent pullback, it's time to start preparing a watchlist of the best bargain stocks to buy. Based on their earnings reports, these bargain stocks are hitting new heights in operating performance. With the economy still in great shape and expectations growing for rate cuts starting in September, they have more upside. Looking at their results, this dis ...
The Cigna Group Foundation Announces Grants to 22 Nonprofits to Help Address the Youth Mental Health Crisis
Prnewswire· 2024-08-05 11:00
BLOOMFIELD, Conn., Aug. 5, 2024 /PRNewswire/ -- The Cigna Group Foundation, the philanthropic arm of The Cigna Group (NYSE: CI), today announced its first round of grant recipients for its new initiative to support youth mental health. As part of this grant program, The Cigna Group Foundation has allocated $9 million to nonprofit organizations over the next three years to intervene in the youth mental health crisis. "At a time when there's been a significant uptick in demand of mental health care, The Cigna ...
Cigna (CI) Q2 Earnings Top on Specialty Business Strength
ZACKS· 2024-08-01 19:11
The Cigna Group (CI) reported second-quarter 2024 adjusted earnings per share (EPS) of $6.72, which beat the Zacks Consensus Estimate by 4.7%. The bottom line improved 9.6% year over year. Adjusted revenues were $60.5 billion, which climbed 24.4% year over year on the back of large client wins in the Evernorth Health Services segment. The top line outpaced the consensus mark by 3.4%. The quarterly results were driven by growth in the Specialty and Care Services businesses within the Evernorth Health Service ...
Cigna(CI) - 2024 Q2 - Earnings Call Transcript
2024-08-01 16:00
The Cigna Group (NYSE:CI) Q2 2024 Earnings Conference Call August 1, 2024 8:30 AM ET Company Participants Ralph Giacobbe - SVP of IR David Cordani - Chairman and CEO Brian Evanko - CFO, and President and CEO, Cigna Healthcare Eric Palmer - President and CEO, Evernorth Health Services Conference Call Participants Justin Lake - Wolfe Research Lisa Gill - JPMorgan A.J. Rice - UBS Andrew Mok - Barclays Scott Fidel - Stephens Ryan Langston - TD Cowen Josh Raskin - Nephron Research George Hill - Deutsche Bank Er ...